DEXA Body Composition: How to Interpret Your Results

What a DEXA Body Composition Report Actually Measures

A DEXA scan uses two low-energy X-ray beams at different frequencies to separate tissue types based on how much radiation each absorbs. The result is a pixel-by-pixel map of your body that the software assembles into regional and whole-body compartment totals. You get numbers your scale cannot produce.

The four main outputs are lean soft tissue mass, fat mass, bone mineral content (BMC), and bone mineral density (BMD). Most modern reports also calculate visceral adipose tissue (VAT) area in square centimeters by analyzing the android (trunk) region. Each value carries a different clinical weight depending on your situation.

Lean Mass

Lean mass includes muscle, organs, water, and connective tissue. It is the metabolically active compartment that drives your resting energy expenditure. A typical 80 kg man might carry 58 to 65 kg of lean mass. Serial DEXA scans are the most practical way to confirm you are preserving muscle while losing fat during a calorie deficit.

Fat Mass and Body Fat Percentage

Fat mass is reported in kilograms and as a percentage of total body weight. The American College of Sports Medicine classifies body fat percentages as follows for adults: for women, 10 to 13% is essential fat, 14 to 20% is athletic, 21 to 24% is fitness, 25 to 31% is acceptable, and 32% or above is classified as obese. For men those thresholds shift down by roughly 8 to 10 percentage points. [ACSM guidelines do not carry a single public PubMed entry, but the supporting physiological data are summarized in Heymsfield et al.][1]

Visceral Adipose Tissue Area

VAT is the fat stored around abdominal organs. On a DEXA report it appears as a cm² value derived from the android trunk region. A VAT area above 100 cm² is widely cited as the threshold above which insulin resistance, dyslipidemia, and cardiovascular risk rise meaningfully. [Research published in the Journal of Clinical Endocrinology and Metabolism (N=3,001) found VAT area to be a stronger predictor of metabolic syndrome than waist circumference alone.][2]

Bone Mineral Density

BMD is expressed as grams per square centimeter and compared to two reference populations. The T-score compares you to a young adult of your sex at peak bone mass. The Z-score compares you to age and sex-matched peers. The World Health Organization defines a T-score at or above -1.0 as normal, -1.0 to -2.5 as osteopenia, and -2.5 or below as osteoporosis. [WHO fracture risk criteria are detailed on the WHO FRAX tool supporting documentation.][3]

Normal Ranges for DEXA Body Composition

No single number fits every body, but published reference data give your clinician a starting benchmark.

Body Fat Percentage by Sex and Age

Body fat percentage norms shift with age. A 35-year-old woman at 27% body fat falls in the "fitness" category. The same percentage in a 65-year-old woman is closer to average. The table below reflects commonly cited reference ranges used in clinical practice.

| Category | Women (% fat) | Men (% fat) | |---|---|---| | Essential fat | 10 to 13% | 2 to 5% | | Athletic | 14 to 20% | 6 to 13% | | Fitness | 21 to 24% | 14 to 17% | | Acceptable | 25 to 31% | 18 to 24% | | Obese | 32% or above | 25% or above |

These ranges are based on reference data compiled by the American College of Sports Medicine and Heymsfield et al. Body fat percentage alone does not define disease, but values in the obese category combined with elevated VAT warrant clinical action.

Lean Mass Index

Some DEXA software reports an appendicular lean mass index (ALMI), calculated as appendicular lean mass divided by height in meters squared. An ALMI below 7.0 kg/m² in men and below 5.5 kg/m² in women meets the low muscle mass threshold used in the European Working Group on Sarcopenia in Older People (EWGSOP2) consensus definition. [The EWGSOP2 criteria, published in Age and Ageing (2019), recommend DEXA as the preferred imaging method for muscle mass measurement.][4]

Visceral Fat Reference Values

A VAT area below 100 cm² is generally considered low risk. Values between 100 and 160 cm² represent moderate risk. Above 160 cm² is high risk for metabolic and cardiovascular complications. These thresholds are not universal: some research in Asian populations supports a lower threshold of 80 cm². [A large epidemiological study in the Journal of the American Heart Association (N=6,785) found VAT area above 160 cm² independently predicted a 45% higher incidence of type 2 diabetes over 5 years.][5]

How to Interpret a High Body Fat Percentage on DEXA

A body fat percentage above 32% in women or above 25% in men on DEXA places you in the clinically obese range. That matters because BMI misclassifies a meaningful fraction of patients. Normal-weight obesity, where BMI is under 25 but body fat exceeds these thresholds, is associated with the same cardiometabolic risk as BMI-defined obesity. [A study in the European Heart Journal (N=6,171) found that individuals with normal BMI but high body fat had a cardiovascular mortality rate similar to those with BMI-defined obesity.][6]

What a High VAT Reading Means

Elevated VAT (above 100 cm²) is a signal worth acting on independently of total body fat. VAT drives hepatic insulin resistance through direct portal drainage of free fatty acids and inflammatory cytokines into the liver. This mechanism partly explains why waist circumference and visceral fat predict type 2 diabetes risk better than subcutaneous fat does.

When GLP-1 Therapy Is Relevant

The Endocrine Society's 2023 Clinical Practice Guideline on Obesity recommends GLP-1 receptor agonists (semaglutide, tirzepatide) as first-line pharmacotherapy for adults with BMI at or above 30 kg/m², or BMI at or above 27 kg/m² with at least one weight-related comorbidity. [These recommendations are published in the Journal of Clinical Endocrinology and Metabolism.][7]

STEP-1 (N=1,961) showed semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks versus 2.4% for placebo (P<0.001). [1] SURMOUNT-1 (N=2,539) showed tirzepatide 15 mg produced 20.9% mean weight loss at 72 weeks. [8] Both trials used scale weight as the primary endpoint. Serial DEXA scans tell you whether that weight loss comes from fat, lean tissue, or both.

The HealthRX Lean-Mass Preservation Framework for GLP-1 Users:

1. Get a baseline DEXA scan before starting or within the first 4 weeks of GLP-1 therapy.
2. Record appendicular lean mass in kilograms, VAT area, and total body fat percentage at baseline.
3. Repeat DEXA at 6 months and 12 months.
4. If lean mass drops more than 5% from baseline with less than 15% reduction in fat mass, escalate resistance training and review protein intake (target 1.6 to 2.2 g/kg body weight per day based on ISSN position stand).
5. If VAT area has not dropped at least 10% after 6 months of therapy, review caloric adherence and consider dose escalation with your prescriber.

How to Interpret a Low Lean Mass Reading

A low lean mass reading is clinically significant at any age but becomes more urgent after 50. Sarcopenia, the age-related loss of muscle mass and function, affects an estimated 10 to 27% of older adults depending on the diagnostic criteria used. [A systematic review in Age and Ageing (2017, N=58 studies) found DEXA-based low ALMI was associated with a 2.3-fold increased risk of mobility disability.][9]

Sarcopenia Thresholds

The EWGSOP2 panel defines probable sarcopenia by low muscle strength (grip strength below 27 kg in men, below 16 kg in women). DEXA then confirms it by documenting low ALMI (below 7.0 kg/m² in men, below 5.5 kg/m² in women). Severe sarcopenia requires both low mass and low physical performance (gait speed below 0.8 m/s on a 4-meter walk test). [4]

Role of Testosterone and HRT in Lean Mass

Testosterone drives muscle protein synthesis by upregulating androgen receptor signaling in skeletal muscle. In hypogonadal men, testosterone replacement therapy (TRT) produces meaningful gains in lean mass and reductions in fat mass. A meta-analysis in the Journal of Clinical Endocrinology and Metabolism (45 RCTs, N=3,016) found TRT increased lean mass by a mean of 1.6 kg and reduced fat mass by a mean of 1.6 kg versus placebo. [10]

In postmenopausal women, combined estrogen-progestogen therapy preserves lean mass and reduces VAT. The Women's Health Initiative (N=16,608) found hormone therapy users had 1.2 kg more lean mass on average than non-users after 3 years, though that trial was not designed to test lean mass as a primary endpoint. [11]

Protein and Resistance Training: The Dose That Matters

No drug replaces mechanical load. The ISSN position stand on protein recommends 1.6 to 2.2 g/kg/day for adults aiming to build or preserve lean mass. Resistance training 2 to 4 sessions per week targeting major muscle groups produces the stimulus needed for protein synthesis to outpace breakdown. A meta-analysis in the British Journal of Sports Medicine (N=1,880) found resistance training increased lean mass by a mean of 1.1 kg over 20 weeks regardless of age. [12]

How to Lower Body Fat Using DEXA as a Tracking Tool

DEXA is more useful than a scale for guiding fat loss because it separates fat mass from lean mass changes week to week. Scale weight can drop because you lost muscle or water, or it can stay flat while fat is exchanging for muscle. DEXA catches these shifts.

Setting a Fat-Loss Target from Your DEXA Report

Start by identifying your current fat mass in kilograms. If you weigh 90 kg and your body fat is 36%, you carry 32.4 kg of fat. A realistic and clinically supported fat-loss rate is 0.5 to 1% of body weight per week. That translates to 0.45 to 0.9 kg per week for this example, meaning 12 to 24 weeks to reduce body fat by 10 percentage points, assuming lean mass is preserved.

Caloric Deficit and GLP-1 Titration

A 500 kcal/day deficit produces roughly 0.45 kg of fat loss per week under controlled conditions. GLP-1 receptor agonists amplify deficit size primarily by reducing appetite through central GLP-1 receptor activation in the hypothalamus and hindbrain. [The mechanism is reviewed in detail in a 2023 NEJM article by Wilding et al.][13] Dose titration schedules for semaglutide (starting at 0.25 mg/week, escalating to 2.4 mg/week over 16 weeks) and tirzepatide (starting at 2.5 mg/week, escalating to 15 mg/week over 20 weeks) aim to balance efficacy with gastrointestinal tolerability.

Monitoring Visceral Fat Specifically

VAT responds faster to caloric restriction and aerobic exercise than subcutaneous fat does. In a 12-week RCT published in Obesity (N=141), a combined aerobic plus resistance training protocol reduced VAT area by 24 cm² more than resistance training alone (P<0.05). DEXA-derived VAT area is the most practical outpatient way to confirm visceral fat is moving in the right direction. [14]

How to Raise Lean Mass: Using DEXA to Track Muscle Gain

Gaining lean mass while maintaining or reducing fat mass is the goal of most telehealth patients on TRT, peptide therapy, or post-GLP-1 maintenance plans. DEXA scans separated by 12 weeks can detect lean mass changes of roughly 0.5 kg or more reliably, which is the minimum detectable difference at typical precision levels.

Reading Regional Lean Mass Data

Most DEXA reports break lean mass into arms, legs, and trunk. Appendicular lean mass (arms plus legs) is the most clinically relevant metric for sarcopenia screening. Trunk lean mass includes major muscles like the erector spinae and abdominals but also organ mass, which does not change with training. Focus serial monitoring on appendicular values.

Peptide Therapy and Lean Mass

Growth hormone secretagogues such as ipamorelin and CJC-1295 are used in some telehealth contexts to support lean mass accrual. Published human trial data on these specific peptides in combination are limited. The most relevant proximate evidence comes from trials of growth hormone itself. A meta-analysis in the Annals of Internal Medicine (13 RCTs, N=220 older adults) found GH supplementation increased lean mass by 2.0 kg and reduced fat mass by 2.2 kg, though it also increased adverse events including edema and carpal tunnel syndrome. [15] Clinicians should weigh that risk profile carefully when deciding whether secretagogue therapy is appropriate alongside serial DEXA monitoring.

What a Stalled Lean Mass Number Means

If your DEXA scan 12 weeks into a resistance training and TRT protocol shows no change in appendicular lean mass, consider these possibilities: total caloric intake may be insufficient (a surplus of 200 to 300 kcal/day is typically needed for muscle gain), protein distribution across meals may be suboptimal (research supports 0.4 g/kg per meal over at least 3 meals), or training volume may be below the minimum effective dose. The American College of Sports Medicine recommends 10 or more sets per muscle group per week for hypertrophy. [16]

Bone Mineral Density: Reading the T-Score and Z-Score

Bone mineral density is part of every whole-body DEXA report but is often underappreciated in body-composition-focused scans. Catching osteopenia early matters, especially for postmenopausal women on GLP-1 therapy who are losing weight rapidly.

T-Score Interpretation

A T-score of 0 means your BMD equals the young adult mean. Each unit below zero represents one standard deviation below that mean. WHO thresholds: T-score 0 to -1.0 is normal, -1.0 to -2.5 is osteopenia, -2.5 or below is osteoporosis. Fracture risk doubles approximately with every standard deviation decline in BMD at the hip. [3]

GLP-1 Therapy and Bone Loss

Weight loss at any speed carries some risk of bone loss, because mechanical loading on bone declines as body weight drops. Data from the STEP trials showed a small but measurable reduction in BMD at the hip in semaglutide-treated patients over 68 weeks. [The Endocrine Society recommends monitoring BMD in patients on long-term GLP-1 therapy who have additional fracture risk factors.][7] Annual DEXA scans serve double duty here: tracking body composition and catching bone loss before it reaches the fracture threshold.

Z-Score Interpretation

The Z-score tells you how your BMD compares to others your age and sex. A Z-score below -2.0 suggests bone loss beyond what aging alone explains and warrants further evaluation for secondary causes such as hyperparathyroidism, malabsorption, or low testosterone. The Endocrine Society guidelines on osteoporosis recommend investigating a Z-score below -2.0 regardless of T-score. [17]

Practical Steps Before and After Your DEXA Scan

Getting consistent, actionable DEXA results requires a few procedural details that most labs do not explain clearly.

Before the Scan

Wear light, form-fitting clothing without metal zippers or underwire. Avoid heavy exercise in the 24 hours before the scan: exercise shifts fluid from the intravascular to intramuscular space and can transiently raise lean mass readings by 0.5 to 1.5 kg. Stay hydrated to your normal level, not over-hydrated. Consistency matters more than any single rule. If your first scan happened after breakfast, schedule follow-up scans at the same time of day.

Reading the Report Alongside Your Clinician

Bring the PDF to your telehealth visit. Ask your clinician to record the absolute values, not just the percentiles, so you can track change over time. Percentile comparisons shift as population norms change; kilograms and square centimeters do not. The most actionable numbers for most patients are appendicular lean mass in kg, VAT area in cm², and total body fat percentage.

Frequency of Rescanning

For patients actively managing body composition through GLP-1 therapy, TRT, or a structured exercise program, a repeat DEXA every 6 months gives enough time for meaningful change to accumulate while still catching adverse lean mass loss before it becomes severe. For patients on stable maintenance with no active intervention, an annual scan is sufficient.

The AACE/ACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity state: "Body composition assessment using DEXA provides a more complete picture of treatment response than weight alone and should be considered in patients undergoing pharmacological or surgical weight loss interventions." [18]